Top

Published in:

01-12-2016 | Review Paper

Predispositions to Lymphoma: A Practical Review for Genetic Counselors

Authors: Morgan Similuk, V. Koneti Rao, Jane Churpek, Michael Lenardo

Published in: Journal of Genetic Counseling | Issue 6/2016

Abstract

This review provides a synopsis for genetic counselors of the major concepts of lymphoma predisposition: genomic instability, immune deficiency, inappropriate lymphoproliferation, and chronic antigen stimulation. We discuss syndromes typifying each of these mechanisms. Importantly, our review of the genetic counseling literature reveals sparse discussion of genetically-based immune-mediated lymphoma predisposition, which we address in depth here. We aim to increase awareness among genetic counselors and colleagues in oncology about familial susceptibility and facilitate critical thinking about lymphoma risk assessment. Clinical application of this knowledge is aided by recommendations for collection of personal and family history to guide risk assessment and testing. Lastly, we include a special discussion of genetic counseling issues including perceptions of the context, nature, and magnitude of lymphoma risk, as well as coping with awareness of susceptibility to lymphoma.

Alkhairy, O. K., Perez-Becker, R., Driessen, G. J., Abolhassani, H., van Montfrans, J., Borte, S., et al. (2015). Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency. Journal of Allergy and Clinical Immunology, 136(3), 703–712.e710.CrossRefPubMed

Angulo, I., Vadas, O., Garçon, F., Banham-Hall, E., Plagnol, V., Leahy, T. R., et al. (2013). Phosphoinositide 3-kinase δ Gene mutation predisposes to respiratory infection and airway damage. Science, 342, 866–871.CrossRefPubMedPubMedCentral

Austin, J. C. (2010). Re-conceptualizing risk in genetic counseling: implications for clinical practice. Journal of Genetic Counseling, 19, 228–234.CrossRefPubMedPubMedCentral

Aydin, S. E., Kilic, S. S., Aytekin, C., Kumar, A., Porras, O., Kainulainen, L.,. Albert, M. H. (2015). DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients. Journal of Clinical Immunology, 35, 189–198.CrossRefPubMed

Bansidhar, B. J. (2012). Extracolonic manifestations of lynch syndrome. Clinics in Colon and Rectal Surgery, 25(2), 103–110.CrossRefPubMedPubMedCentral

Bienemann, K., Borkhardt, A., Klapper, W., & Oschlies, I. (2015). High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency (pp. 1–10). Epub: Histopathology.

Biesecker, B. B., Schwartz, M. D., & Marteau, T. M. (2013). Enhancing informed choice to undergo health screening: a systematic review. American Journal of Health Behavior, 37, 351–359.CrossRefPubMedPubMedCentral

Birch, J. M., Alston, R. D., McNally, R. J., Evans, D. G., Kelsey, a. M., Harris, M.,. Varley, J. M. (2001). Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene, 20, 4621–4628.CrossRefPubMed

Booth, C., Gilmour, K. C., Veys, P., Gennery, A. R., Slatter, M. a., Chapel, H., et al. (2010). X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management, and outcome of the disease. Blood, 117, 53–63.CrossRefPubMed

Caporaso, N. E., Goldin, L. R., Anderson, W. F., & Landgren, O. (2009). Current insight on trends, causes, and mechanisms of Hodgkin's lymphoma. Cancer Journal, 15(2), 117–123.CrossRef

Chiu, B. C., & Hou, N. (2015). Epidemiology and etiology of non-Hodgkin lymphoma. Cancer Treatment and Research, 165, 1–25.CrossRefPubMed

Chua, I., Quinti, I., & Grimbacher, B. (2008). Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics. Current Opinion in Hematology, 15, 368–374.CrossRefPubMed

Churpek, J. E., & Onel, K. (2010). Heritability of hematologic malignancies: from pedigrees to genomics. Hematology/Oncology Clinics of North America, 24, 939–972.CrossRefPubMed

Churpek, J. E., Lorenz, R., Nedumgottil, S., Onel, K., Olopade, O. I., Sorrell, A.,. Godley, L. a. (2013). Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes. Leukemia and Lymphoma, 54, 28–35.CrossRefPubMed

Clementi, R., Locatelli, F., Dupré, L., Garaventa, A., Emmi, L., Bregni, M.,. Roncarolo, M. G. (2005). A proportion of patients with lymphoma may harbor mutations of the perform gene. Blood, 105, 4424–4428.CrossRefPubMed

Crank, M., Grossman, J., Moir, S., Pittaluga, S., Buckner, C., Kardava, L.,. Rosenzweig, S. (2014). Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility. Journal of Clinical Immunology, 34, 272–276.CrossRefPubMedPubMedCentral

Cunningham-Rundles, C. (2012). The many faces of common variable immunodeficiency. Hematology, 301–305.

Daly, M. B., Lerman, C. L., Ross, E., Schwartz, M. D., Sands, C. B., & Masny, A. (1996). Gail model breast cancer risk components are poor predictors of risk perception and screening behavior. Breast Cancer Research and Treatment, 41, 59–70.CrossRefPubMed

Ehrenfeld, M., Abu-Shakra, M., Buskila, D., & Shoenfeld, Y. (2001). The dual association between lymphoma and autoimmunity. Blood Cells, Molecules & Diseases, 27, 750–756.CrossRef

Ellis, C. N. (2010). Inherited Cancer Syndromes: Current Clinical Management. (C. N. Ellis Ed. 2nd (Edition ed.). New York: Springer.

Fagerline, A., Zikmund-Fisher, B. J., & Ubel, P. A. (2011). Helping patients decide: ten steps to better risk communication. Journal of the National Cancer Institute, 103, 1–8.CrossRef

Fisher, S. G., & Fisher, R. I. (2004). The epidemiology of non-Hodgkin's lymphoma. Oncogene, 23, 6524–6534.CrossRefPubMed

Flanagan, S. E., Haapaniemi, E., Russell, M. a., Caswell, R., Allen, H. L., De Franco, E.,. Hattersley, A. T. (2014). Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nature Genetics, 46, 812–814.CrossRefPubMedPubMedCentral

Folkman, S. (1984). Personal control and stress and coping processes: a theoretical analysis. Journal of Personality and Society Psychology, 46, 4:839-852.

Gatti, R. A., & Good, R. A. (1971). Occurrence of malignancy in immunodeficiency diseases. Cancer, 28(89–99).

German, J. (1997). Bloom's syndrome: the first 100 cancers. Cancer Genetics and Cytogenetics, 93, 100–106.CrossRefPubMed

Ghosh, S., Bienemann, K., Boztug, K., & Borkhardt, A. (2014). Interleukin-2-inducible T-cell kinase (ITK) deficiency - clinical and molecular aspects. Journal of Clinical Immunology, 34, 892–899.CrossRefPubMedPubMedCentral

Goldgar, D. E., Easton, D. F., Cannon-Albright, L. a., & Skolnick, M. H. (1994). Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. JNCI Journal of the National Cancer Institute, 86, 1600–1608.CrossRefPubMed

Goldin, L. R., Landgren, O., McMaster, M. L., Gridley, G., Hemminki, K., Li, X., et al. (2005). Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiology, Biomarkers & Prevention, 14, 2402–2406.CrossRef

Gonzalez, K. D., Noltner, K. a., Buzin, C. H., Gu, D., Wen-Fong, C. Y., Nguyen, V. Q., et al. (2009). Beyond Li-Fraumeni syndrome: clinical characteristics of families with p53 germline mutations. Journal of Clinical Oncology, 27, 1250–1256.CrossRefPubMed

Gooding, H. C., Organista, K., Burack, J., & Biesecker, B. B. (2006). Genetic susceptibility testing from a stress and coping perspective. Social Science & Medicine (1982), 62, 1880–1890.

Grover, S., Stoffel, E. M., Bussone, L., Tschoegl, E., & Syngal, S. (2004). Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clinical Gastroenterology and Hepatology, 2, 813–819.CrossRefPubMed

Hirbod-Mobarakeh, A., Aghamohammadi, A., & Rezaei, N. (2014). Immunoglobulin class switch recombination deficiency type 1 or CD40 ligand deficiency: from bedside to bench and back again. Expert Review of Clinical Immunology, 10(1), 91–105.CrossRefPubMed

Holmfeldt, L., Wei, L., Diaz-Flores, E., Walsh, M., Zhang, J., Ding, L., et al. (2013). The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nature Genetics, 45(3), 242–252.CrossRefPubMedPubMedCentral

Hughes, C., Lerman, C., Schwartz, M., Peshkin, B. N., Wenzel, L., Narod, S., et al. (2002). All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. American Journal of Medical Genetics, 107, 143–150.CrossRefPubMed

Kanegane, H., Yang, X., Zhao, M., Yamato, K., Inoue, M., Hamamoto, K., et al. (2012). Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis. Pediatric Allergy and Immunology, 23, 488–493.CrossRefPubMed

Kondratenko, I., Paschenko, O., Polyakov, A., & Bologov, A. (2000). Nijmegen breakage syndrome. Archives of Diseases in Childhood, 82, 400–406.CrossRef

Kuehn, H. S., Ouyang, W., Lo, B., Deenick, E. K., Niemela, J. E., Avery, D. T., et al. (2013). Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science, 345, 1623–1627.CrossRef

Leechawengwongs, E., & Shearer, W. T. (2012). Lymphoma complicating primary immunodeficiency syndromes. Current Opinion in Hematology, 19, 305–312.CrossRefPubMed

Li, F.-Y., Chaigne-Delalande, B., Kanellopoulou, C., Davis, J. C., Matthews, H. F., Douek, D. C.,. Lenardo, M. J. (2011). Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature, 475, 471–476.CrossRefPubMedPubMedCentral

Li, F.-Y., Chaigne-Delalande, B., Su, H., Uzel, G., Matthews, H., & Lenardo, M. J. (2014). XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus. Blood, 123, 2148–2152.CrossRefPubMedPubMedCentral

Lipinski, S. E., Lipinski, M. J., Biesecker, L. G., & Biesecker, B. B. (2006). Uncertainty and perceived personal control among parents of children with rare chromosome conditions: the role of genetic counseling. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 142C(4), 232–240.CrossRef

Lucas, C. L., Kuehn, H. S., Zhao, F., Niemela, J. E., Deenick, E. K., Palendira, U., et al. (2014). Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency. Nature Immunology, 15, 88–97.CrossRefPubMed

Mackay, I. R., & Rose, N. R. (2001). Autoimmunity and lymphoma: tribulations of B cells. Nature Immunology, 2, 793–795.CrossRefPubMed

Milner, J. D., & Holland, S. M. (2013). The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases. Nature Reviews Immunology, 13, 635–648.

Milner, J. D., Vogel, T. P., Forbes, L., Ma, C. A., Stray-Pedersen, A., Niemela, J. E.,. Cooper, M. A. (2015). Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood, 125(4), 591–599.CrossRefPubMedPubMedCentral

Mitchell, J. M., & Conklin, E. A. (2015). Factors affecting receipt of expensive cancer treatments and mortality: evidence from stem cell transplantation for leukemia and lymphoma. Health Services Research, 50(1), 197–216.CrossRefPubMed

Murff, H. J., Byrne, D., & Syngal, S. (2004). Cancer risk assessment: quality and impact of the family history interview. American Journal of Preventive Medicine, 27, 239–245.PubMed

Murphy, K. (2012). Janeway's Immunobiology (8th ed.). London and New York: Garland Science.

Ngalamika, O., Zhang, Y., Yin, H., Zhao, M., Gershwin, M. E., & Lu, Q. (2012). Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review. Journal of Autoimmunity, 39, 451–465.CrossRefPubMed

Ochs, H. D., & Thrasher, A. J. (2006). The Wiskott-Aldrich syndrome. Journal of Allergy and Clinical Immunology, 117(4), 725–738 quiz 739.CrossRefPubMed

Pachlopnik Schmid, J., Canioni, D., Moshous, D., Touzot, F., Mahlaoui, N., Hauck, F.,. Latour, S. (2011). Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood, 117(5), 1522–1529.CrossRefPubMed

Patenaude, A. F., Dorval, M., DiGianni, L. S., Schneider, K. a., Chittenden, A., & Garber, J. E. (2006). Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. Journal of Clinical Oncology, 24, 700–706.CrossRefPubMed

Peshkin, B. N., DeMarco, T., & Tercyak, K. P. (2010). On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children. Familial Cancer, 9, 89–97.CrossRefPubMed

Poppema, S., Maggio, E., & Van Den Berg, A. (2004). Development of lymphoma in autoimmune lymphoproliferative syndrome (ALPS) and its relationship to FAS Gene mutations. Leukemia and Lymphoma, 45(3), 423–431.CrossRefPubMed

Price, S., Shaw, P. A., Seitz, A., Joshi, G., Davis, J., Niemela, J. E., et al. (2014). Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood, 123, 1989–2000.CrossRefPubMedPubMedCentral

Ravell, J., Chaigne-Delalande, B., & Lenardo, M. (2014). X-linked immunodeficiency with magnesium defect, Epstein–Barr virus infection, and neoplasia disease. Current Opinion in Pediatrics, 26, 713–719.CrossRefPubMedPubMedCentral

Resta, R., Biesecker, B. B., Bennett, R. L., Blum, S., Hahn, S. E., Strecker, M. N.,.. . Force, N. S. o. G. C. D. T. (2006). A new definition of genetic counseling: National Society of genetic Counselors' task force report. Journal of Genetic Counseling, 15(2), 77–83.

Rezaei, N., Hedayat, M., Aghamohammadi, A., & Nichols, K. E. (2011). Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. The Journal of Allergy and Clinical Immunology, 127, 1329–1341.e1322; quiz 1342-1323.

Rohr, J., Beutel, K., Maul-Pavicic, A., Vraetz, T., Thiel, J., Warnatz, K., et al. (2010). Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases. Haematologica, 95, 2080–2087.CrossRefPubMedPubMedCentral

Rossi, D., Ciardullo, C., & Gaidano, G. (2013). Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies. Seminars in Cancer Biology, 23, 422–430.CrossRefPubMed

Saarinen, S., Aavikko, M., Aittomaki, K., Launonen, V., Lehtonen, R., Franssila, K., et al. (2011). Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma. Blood, 118(3), 493–498.CrossRefPubMed

Salipante, S. J., Mealiffe, M. E., Wechsler, J., Krem, M. M., Liu, Y., Namkoong, S., et al. (2009). Mutations in a Gene encoding a Midbody Kelch protein in familial and sporadic classical Hodgkin lymphoma lead to Binucleated cells. Proceedings of the National Academy of Sciences of the United States of America, 106(35), 14920–14925.CrossRefPubMedPubMedCentral

Schneider, K. A. (2011). Counseling about Cancer: Strategies for Genetic Counseling (K. A. Schneider Ed. 3rd (edition ed.). Hoboken, NJ: John Wiley & Sons.CrossRef

Segel, G. (2004). Familial (inherited) leukemia, lymphoma, and myeloma: an overview. Blood Cells, Molecules, and Diseases, 32, 246–261.CrossRefPubMed

Seidel, M. G. (2014). Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment. Blood, 124, 2337–2344.CrossRefPubMedPubMedCentral

Shiloh, S. (2006). Illness representations, self-regulation, and genetic counseling: a theoretical review. Journal of Genetic Counseling, 15(5), 325–337.CrossRefPubMed

Siddiqui, R., Onel, K., Facio, F., & Offit, K. (2004). The genetics of familial lymphomas. Current Oncology Reports, 6(5), 380–387.CrossRefPubMed

Snow, A. L., Xiao, W., Stinson, J. R., Lu, W., Chaigne-Delalande, B., Zheng, L., et al. (2012). Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. The Journal of Experimental Medicine, 209, 2247–2261.CrossRefPubMedPubMedCentral

Stern, M., Buser, A. S., Lohri, A., Tichelli, A., & Nissen-Druey, C. (2007). Autoimmunity and malignancy in hematology–more than an association. Critical Reviews in Oncology/Hematology, 63, 100–110.CrossRefPubMed

Stiller, C. a., Chessells, J. M., & Fitchett, M. (1994). Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. British Journal of Cancer, 70, 969–972.CrossRefPubMedPubMedCentral

Straus, S. E. (2001). The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline FAS mutations and defective lymphocyte apoptosis. Blood, 98, 194–200.CrossRefPubMed

Su, H. C., Jing, H., & Zhang, Q. (2011). DOCK8 deficiency. Annals of the New York Academy of Sciences, 1246, 26–33.CrossRefPubMed

Suarez, F., Mahlaoui, N., Canioni, D., Andriamanga, C., Dubois d'Enghien, C., Brousse, N., et al. (2015). Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. Journal of Clinical Oncology, 33(2), 202–208.CrossRefPubMed

Sullivan, K. E., Mullen, C. a., Blaese, R. M., & Winkelstein, J. a. (1994). A multiinstitutional survey of the Wiskott-Aldrich syndrome. Journal of Pediatrics, 125, 876–885.CrossRefPubMed

Taylor, A., Metcalfe, J., Thick, J., & Mak, Y.-F. (1996). Leukemia and lymphoma in ataxia telangiectasia. Blood, 87, 423–438.PubMed

Tercyak, K. P., Peshkin, B. N., DeMarco, T. a., Brogan, B. M., & Lerman, C. (2002). Parent–child factors and their effect on communicating BRCA1/2 test results to children. Patient Education and Counseling, 47, 145–153.CrossRefPubMed

Tran, H., Nourse, J., Hall, S., Green, M., Griffiths, L., & Gandhi, M. K. (2008). Immunodeficiency-associated lymphomas. Blood Reviews, 22, 261–281.CrossRefPubMed

Vadaparampil, S. T., Malo, T., de la Cruz, C., & Christie, J. (2012). Do breast cancer patients tested in the oncology care setting share BRCA mutation results with family members and health care providers? Journal of Cancer Epidemiology, 2012, 1–10.CrossRef

Vaqué, J. P., Martínez, N., Batlle-López, A., Pérez, C., Montes-Moreno, S., Sánchez-Beato, M., et al. (2014). B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies. Haematologica, 99, 222–231.CrossRefPubMedPubMedCentral

Vardiman, J. W., Harris, N. L., & Brunning, R. D. (2002). The World Health Organization (WHO) classification of the myeloid neoplasms. Blood, 100(7), 2292–2302.CrossRefPubMed

Wimmer, K., Kratz, C. P., Vasen, H. F., Caron, O., Colas, C., Entz-Werle, N., et al. (2014). Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the. European consortium 'care for CMMRD' Journal of Medical Genetics, 51(6), 355–365.PubMed

Title: Predispositions to Lymphoma: A Practical Review for Genetic Counselors
Authors: Morgan Similuk
V. Koneti Rao
Jane Churpek
Michael Lenardo
Publication date: 01-12-2016
Publisher: Springer US
Published in: Journal of Genetic Counseling / Issue 6/2016
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-016-9979-0

At a glance: The STEP trials

Springer Medicine

Predispositions to Lymphoma: A Practical Review for Genetic Counselors

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2016

Experience of Social Media Support Group for BRCA Carriers

Presented Abstracts from the Thirty Fifth Annual Education Conference of the National Society of Genetic Counselors (Seattle, WA, September 2016)

The Psychological Impact of Prenatal Diagnosis and Disclosure of Susceptibility Loci: First Impressions of Parents’ Experiences

Why Do Parents Want to Know their Child’s Carrier Status? A Qualitative Study

How do Physicians Decide to Refer Their Patients for Psychiatric Genetic Counseling? A Qualitative Study of Physicians’ Practice

Understanding the Psychosocial Effects of WES Test Results on Parents of Children with Rare Diseases